Replies to post #159993 on Innovation Pharmaceuticals Inc (IPIX)

[Rdunn88]

Must read on phase costs. Interesting how the average cost of trials increase a few million each-year. So the longer the delay "in any trial" the costs will increase. 30 million over 2 years could easily go up... So, the need to find better financing will only magnify. Once again, putting all-the-pressure on P to find a partner...

https://www.quora.com/How-much-do-clinical-trials-for-drugs-cost

[BonelessCat]

P is already a success. It can't fail. Even if it is less effective against moderate to severe cases, they will market it against less severe cases due to its very low toxicity, which has already been demonstrated.

[sox040713]

I don't think you understood my post. CTIX does NOT need to raise the $30M if they can find a partner for ABSSSI, even if P fails. The partner will pay for P3. According to NR, B is a lock vs. Vancomycin in P3. So who wouldn't want a potentially $1B drug?

So if P fails, you expect nothing to be effected, therefore CTIX can easily raise 30 million over 2 years?

[MinnieM]

Prurisol has already shown effectiveness in the last trial. I view the next trial more as dose optimization.






In Reply to 'Rdunn88'
So if P fails, you expect nothing to be effected, therefore CTIX can easily raise 30 million over 2 years? LOL